DMD and Duchenne muscular dystrophy: Furthermore, we assessed the effect that intramuscularly or systemically administered antisense morpholino oligomer (eteplirsen), which induces targeted skipping of exon 51 and dystrophin restoration, had on the expression level of these miRNAs in DMD patients included in two completed eteplirsen clinical trials [18], [19].